Relief of urinary symptom burden after primary prostate cancer treatment

dc.contributor.authorChang, Peter
dc.contributor.authorRegan, Meredith M.
dc.contributor.authorFerrer, Montserrat
dc.contributor.authorGuedea Edo, Ferran
dc.contributor.authorPatil, Dattatraya
dc.contributor.authorWei, John T.
dc.contributor.authorHembroff, Larry A.
dc.contributor.authorJeff M. Michalski
dc.contributor.authorSaigal, Chris S.
dc.contributor.authorLitwin, Mark S.
dc.contributor.authorHamstra, Daniel A.
dc.contributor.authorKaplan, Irving D.
dc.contributor.authorCiezki, Jay P.
dc.contributor.authorKlein, Eric A.
dc.contributor.authorKibel, Adam S.
dc.contributor.authorSandler, Howard M.
dc.contributor.authorDunn, Rodney L.
dc.contributor.authorCrociani, Catrina M.
dc.contributor.authorSanda, Martin G.
dc.contributor.authorPROST-QA Consortium
dc.date.accessioned2017-03-24T12:50:28Z
dc.date.available2017-09-02T22:01:28Z
dc.date.issued2016-09-02
dc.date.updated2017-03-24T12:50:29Z
dc.description.abstractPurpose: Harms of prostate cancer treatment on urinary health related quality of life have been thoroughly studied. In this study we evaluated not only the harms but also the potential benefits of prostate cancer treatment in relieving the pretreatment urinary symptom burden. Materials and Methods: In American (1,021) and Spanish (539) multicenter prospective cohorts of men with localized prostate cancer we evaluated the effects of radical prostatectomy, external radiotherapy or brachytherapy in relieving pretreatment urinary symptoms and in inducing urinary symptoms de novo, measured by changes in urinary medication use and patient reported urinary bother. Results: Urinary symptom burden improved in 23% and worsened in 28% of subjects after prostate cancer treatment in the American cohort. Urinary medication use rates before treatment and 2 years after treatment were 15% and 6% with radical prostatectomy, 22% and 26% with external radiotherapy, and 19% and 46% with brachytherapy, respectively. Pretreatment urinary medication use (OR 1.4, 95% CI 1.0-2.0, p = 0.04) and pretreatment moderate lower urinary tract symptoms (OR 2.8, 95% CI 2.2-3.6) predicted prostate cancer treatment associated relief of baseline urinary symptom burden. Subjects with pretreatment lower urinary tract symptoms who underwent radical prostatectomy experienced the greatest relief of pretreatment symptoms (OR 4.3, 95% CI 3.0-6.1), despite the development of deleterious de novo urinary incontinence in some men. The magnitude of pretreatment urinary symptom burden and beneficial effect of cancer treatment on those symptoms were verified in the Spanish cohort. Conclusions: Men with pretreatment lower urinary tract symptoms may experience benefit rather than harm in overall urinary outcome from primary prostate cancer treatment. Practitioners should consider the full spectrum of urinary symptom burden evident before prostate cancer treatment in treatment decisions.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec669368
dc.identifier.issn0022-5347
dc.identifier.pmid27593476
dc.identifier.urihttps://hdl.handle.net/2445/108884
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.juro.2016.08.101
dc.relation.ispartofJournal of Urology, 2016, vol. 197, num. 2, p. 376-384
dc.relation.urihttps://doi.org/10.1016/j.juro.2016.08.101
dc.rightscc-by-nc-nd (c) Elsevier B.V., 2016
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationCàncer de pròstata
dc.subject.classificationQualitat de vida
dc.subject.classificationAvaluació de resultats (Assistència mèdica)
dc.subject.classificationCura dels malalts
dc.subject.classificationAparell urinari
dc.subject.classificationAmèrica
dc.subject.classificationEspanya
dc.subject.otherProstate cancer
dc.subject.otherQuality of life
dc.subject.otherOutcome assessment (Medical care)
dc.subject.otherCare of the sick
dc.subject.otherUrinary organs
dc.subject.otherAmerica
dc.subject.otherSpain
dc.titleRelief of urinary symptom burden after primary prostate cancer treatment
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
669368.pdf
Mida:
767.94 KB
Format:
Adobe Portable Document Format